Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micropillar-Based Biosensor for Monitoring Contamination- and Compound-Induced Metabolic States in Cell Cultures.

ACS applied materials & interfaces·2026
Same author

Light-Activated Isolation of High-Quality Mitochondria for Therapeutic Transplantation.

Angewandte Chemie (International ed. in English)·2026
Same author

Poking Pluripotency: Nanoinjection Into Human iPSCs.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Hybrid macrophage-mitochondria extracellular vesicles for mitochondrial ROS regulation in diabetic wounds.

Nature communications·2026
Same author

Electrochemical β-Lactam Probes for Rapid Detection of β-Lactamases: From Solution-Phase Activation toward Surface-Integrated Biosensing.

Journal of the American Chemical Society·2026
Same author

Fine-Tuning Lipid-Coated Porous Silicon Nanoparticles for siRNA Delivery.

Advanced healthcare materials·2025
Same journal

Navigating the Forest of Lignin-Derived Monomers for Polymer Synthesis.

Biomacromolecules·2026
Same journal

Degradable Cationic Polyesters with Tunable Anion-Induced Upper Critical Solution Temperature Coacervation.

Biomacromolecules·2026
Same journal

Understanding Lignin Radical Dynamics: Quenching Radicals by Solvent and Thermal Induced Mobility.

Biomacromolecules·2026
Same journal

Anomalous Diffusion of Nanoparticles in Semidilute Hyaluronic Acid Solutions.

Biomacromolecules·2026
Same journal

Unraveling Self-Assembly Mechanisms in Bacterial Cellulose Hydrogels.

Biomacromolecules·2026
Same journal

Engineering Coil-Coiled Domains for the Design of Modular Theranostic Agents: Galectin-3 as a Targeting Moiety.

Biomacromolecules·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

11.0K

Surface-Engineered Porous Silicon Nanoparticles for Targeted Osteosarcoma Therapy.

Mona A Abdelmoneem1,2,3, Lars Esser4,5, Marcin Wojnilowicz4,5

  • 1Department of Materials Science & Engineering, Monash University, Clayton, Victoria 3168, Australia.

Biomacromolecules
|July 29, 2025
PubMed
Summary
This summary is machine-generated.

Researchers developed novel bone-targeted nanoparticles for delivering doxorubicin chemotherapy to treat osteosarcoma. These alendronate-conjugated porous silicon nanoparticles show enhanced drug delivery and efficacy against cancer cells.

More Related Videos

Designing Porous Silicon Films as Carriers of Nerve Growth Factor
10:12

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Published on: January 25, 2019

9.9K
Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
08:53

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

7.8K

Related Experiment Videos

Last Updated: May 6, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

11.0K
Designing Porous Silicon Films as Carriers of Nerve Growth Factor
10:12

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Published on: January 25, 2019

9.9K
Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
08:53

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

7.8K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Oncology

Background:

  • Osteosarcoma is an aggressive bone cancer with limited treatment options.
  • Targeted nanocarriers offer a promising approach for delivering chemotherapy to bone.
  • Developing effective drug delivery systems is crucial for improving osteosarcoma treatment outcomes.

Purpose of the Study:

  • To develop and evaluate a bone-targeted nanocarrier system for doxorubicin delivery in osteosarcoma.
  • To functionalize porous silicon nanoparticles with alendronate for enhanced bone targeting.
  • To assess the drug loading, release kinetics, and in vitro efficacy of the targeted nanocarriers.

Main Methods:

  • Synthesis of alendronate-conjugated poly(N-(2-hydroxypropyl)acrylamide)-functionalized porous silicon nanoparticles (ALN-PolyHPAm@D-pSiNPs).
  • Evaluation of doxorubicin loading capacity, pH-responsive release, and antifouling properties.
  • Assessment of hydroxyapatite-binding affinity and cellular uptake in Saos-2 osteosarcoma cells.
  • In vitro cytotoxicity assays comparing targeted nanoparticles with non-targeted nanoparticles and free doxorubicin.

Main Results:

  • The developed nanoparticles exhibited high doxorubicin loading capacity and sustained, pH-responsive drug release.
  • ALN-PolyHPAm@D-pSiNPs demonstrated strong hydroxyapatite-binding affinity and selective uptake in osteosarcoma cells.
  • Doxorubicin-loaded targeted nanoparticles showed significantly enhanced in vitro cytotoxicity against Saos-2 cells compared to controls.

Conclusions:

  • The bone-targeted porous silicon nanoparticle platform effectively delivers doxorubicin for osteosarcoma treatment.
  • Alendronate conjugation enhances nanoparticle targeting to bone tissue.
  • This nanocarrier system holds significant promise for improving osteosarcoma therapy.